Vaccines
Overview
Vaccines is a peer-reviewed open-access journal that focuses on all aspects of vaccines, including development, efficacy, safety, and public health impact. It publishes high-quality research articles, reviews, and communications, providing a platform for scientists, clinicians, and policymakers to share advancements in vaccine research and contribute to the global effort in disease prevention and control.
Details
Details
Abbr.
Vaccines (Basel)
Start
2012
End
Continuing
Frequency
Quarterly
e-ISSN
2076-393X
Country
Switzerland
Language
English
Metrics
Metrics
h-index / Ranks: 4009
85
SJR / Ranks: 2828
1201
CiteScore / Ranks: 2894
7.00
JIF / Ranks: 720
7.8
Recent Articles
1.
Patel N, Davis Z, Hofmann C, Vlasak J, Loughney J, DePhillips P, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006754
The authors would like to make the following corrections to this published paper [...].
2.
Aves K, Fresno A, Nisar S, Saraiva M, Goecke N, Sander A, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006753
Background: (LI) is the agent of proliferative enteropathy in swine, a common disease that affects pigs for up to eight weeks after weaning. Aim: To evaluate the effectiveness of two...
3.
De Meyst A, Van Mieghem J, Chiers K, Raemdonck K, Verbeke R, Lentacker I, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006752
Background/objectives: is an avian respiratory pathogen that regularly infects budgerigars () and is a known zoonosis. This study aimed to evaluate the efficacy of a nucleoside-modified mRNA vaccine formulated in...
4.
Giri S, Batra L
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006751
Memory cells are central to the adaptive immune system's ability to remember and respond effectively to previously encountered pathogens. While memory cells provide robust protection against infections, they can also...
5.
Kilany W, Safwat M, Zain El-Abideen M, Hisham I, Moussa Y, Ali A, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006750
Background/objective: Highly pathogenic avian influenza (HPAI) H5 subtype remains a significant menace to both the poultry industry and human public health. Biosecurity and mass vaccination of susceptible commercial poultry flocks...
6.
Bianchi F, Giotta M, Martinelli A, Giurgola M, Del Matto G, Mastrovito E, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006749
Background: Splenectomized/asplenic individuals are at a heightened risk for severe infections due to compromised immune function. However, the impact of splenectomy/asplenia on COVID-19 outcomes remains underexplored. This study aims to...
7.
Miryala K, Swain B
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006748
presents a significant threat to global aquaculture due to its ability to infect freshwater and marine fish species, leading to substantial economic losses. Effective mitigation methods are essential to address...
8.
Du Q, Meng Q, Shi W, Yao K
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006747
Objectives: China was once a country with a high incidence of pertussis, with reported incidence rates exceeding 100 per 100,000 before the introduction of the pertussis vaccine. After the widespread...
9.
Lien A, Johnson G, Guan T, Burns C, Parker J, Dong L, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006746
Since the introduction of prophylactic HPV vaccines, both HPV infection rates and cervical cancer rates have subsequently dropped. Yet, cervical cancer remains the fourth most common cancer diagnosis in women...
10.
Sheikhi A, Baghaie L, Rahbarizadeh F, Safarzadeh Kozani P, Moradian C, Davidi M, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006745
: The SARS-CoV-2's high mutations and replication rates contribute to its high infectivity and resistance to current vaccinations and treatments. The primary cause of resistance to most current treatments aligns...